Anastrozole versus tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial: Margolese RG, Cecchini RS, Julian TB, et al (NRG Oncology/Natl Surgical Adjuvant Breast and Bowel Project (NSABP), Pittsburgh, PA) Lancet 387:849-856, 2016§